Kun Tu

646 total citations
12 papers, 529 citations indexed

About

Kun Tu is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Kun Tu has authored 12 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 6 papers in Biomedical Engineering. Recurrent topics in Kun Tu's work include Immunotherapy and Immune Responses (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Kun Tu is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Kun Tu collaborates with scholars based in China, United Kingdom and Macao. Kun Tu's co-authors include Li Kong, Qian Hu, Zhiping Zhang, Mei Hu, Yulin Yu, Ting Yang, Conglian Yang, Xianya Qin, Huan Deng and Zhiping Zhang and has published in prestigious journals such as ACS Nano, Biomaterials and ACS Applied Materials & Interfaces.

In The Last Decade

Kun Tu

12 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kun Tu China	11	259	231	167	142	123	12	529
Bilan Wang China	13	265 1.0×	248 1.1×	141 0.8×	148 1.0×	187 1.5×	18	659
Jingyi An China	12	254 1.0×	352 1.5×	128 0.8×	63 0.4×	147 1.2×	21	637
Tianjiao Chu China	9	164 0.6×	222 1.0×	73 0.4×	89 0.6×	140 1.1×	19	523
Aram Shajii United States	6	325 1.3×	211 0.9×	70 0.4×	77 0.5×	161 1.3×	6	573
Zhenwei Su China	11	214 0.8×	321 1.4×	161 1.0×	142 1.0×	185 1.5×	12	589
Zi-Dong Lu China	12	523 2.0×	207 0.9×	163 1.0×	90 0.6×	109 0.9×	24	815
Erica N. Bozeman United States	13	209 0.8×	161 0.7×	211 1.3×	176 1.2×	121 1.0×	20	524
Zhangyi Luo United States	14	257 1.0×	193 0.8×	162 1.0×	123 0.9×	145 1.2×	22	555
Manisit Das United States	13	279 1.1×	342 1.5×	338 2.0×	302 2.1×	215 1.7×	17	810
Elizabeth E. Sweeney United States	15	235 0.9×	470 2.0×	243 1.5×	202 1.4×	109 0.9×	21	786

Countries citing papers authored by Kun Tu

Since Specialization

Citations

This map shows the geographic impact of Kun Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Tu more than expected).

Fields of papers citing papers by Kun Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Tu. The network helps show where Kun Tu may publish in the future.

Co-authorship network of co-authors of Kun Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Tu. A scholar is included among the top collaborators of Kun Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Tu. Kun Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Li, Qing Yun, Yanping Li, Fang Jin, et al.. (2025). Inhibition of tRF- 02514 in Extracellular Vesicles Preserves Microglia Pyroptosis and Protects Against Parkinson’s Disease. Molecular Neurobiology. 62(9). 11047–11063. 1 indexed citations

Tu, Kun, Yulin Yu, Yi Wang, et al.. (2021). Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade. ACS Applied Materials & Interfaces. 13(33). 39003–39017. 51 indexed citations

Hu, Mei, Jianyu Zhang, Li Kong, et al.. (2021). Immunogenic Hybrid Nanovesicles of Liposomes and Tumor-Derived Nanovesicles for Cancer Immunochemotherapy. ACS Nano. 15(2). 3123–3138. 137 indexed citations

Tu, Jingyao, Kun Tu, Haoran Xu, et al.. (2020). Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy. European Journal of Pharmaceutics and Biopharmaceutics. 150. 96–107. 20 indexed citations

Tu, Kun, Huan Deng, Li Kong, et al.. (2020). Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death. ACS Applied Materials & Interfaces. 12(14). 16018–16030. 99 indexed citations

Hu, Mei, Jianyu Zhang, Yulin Yu, et al.. (2020). Injectable Liquid Crystal Formation System for Reshaping Tumor Immunosuppressive Microenvironment to Boost Antitumor Immunity: Postoperative Chemoimmunotherapy. Small. 16(50). e2004905–e2004905. 21 indexed citations

Hu, Qian, Lihuan Shang, Mengmeng Wang, et al.. (2020). Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy. Advanced Healthcare Materials. 9(10). e1901858–e1901858. 48 indexed citations

Yang, Conglian, Kun Tu, Hanlu Gao, et al.. (2019). The novel platinum(IV) prodrug with self-assembly property and structure-transformable character against triple-negative breast cancer. Biomaterials. 232. 119751–119751. 28 indexed citations

Deng, Huan, Songwei Tan, Xueqin Gao, et al.. (2019). Cdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunity. Acta Pharmaceutica Sinica B. 10(2). 358–373. 77 indexed citations

10.

Yang, Conglian, et al.. (2018). Star-shaped polymer of β‑cyclodextrin-g-vitamin E TPGS for doxorubicin delivery and multidrug resistance inhibition. Colloids and Surfaces B Biointerfaces. 169. 10–19. 23 indexed citations

11.

Li, Qian, Jiangeng Huang, Kun Tu, et al.. (2018). In vitro effect of mPEG2k-PCLx micelles on rat liver cytochrome P450 enzymes. International Journal of Pharmaceutics. 552(1-2). 99–110. 12 indexed citations

12.

Qiao, Yuben, Kun Tu, Wenya Feng, et al.. (2018). Polyketide and Prenylxanthone Derivatives from the Endophytic Fungus Aspergillus sp. TJ23. Chemistry & Biodiversity. 15(12). e1800395–e1800395. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact